169 related articles for article (PubMed ID: 35322195)
21. Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments.
Franchi A; Innocenti DR; Palomba A; Miligi L; Paiar F; Franzese C; Santucci M
Pathol Oncol Res; 2014 Jul; 20(3):571-9. PubMed ID: 24338245
[TBL] [Abstract][Full Text] [Related]
22. Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations.
Chraybi M; Abd Alsamad I; Copie-Bergman C; Baia M; André J; Dumaz N; Ortonne N
Hum Pathol; 2013 Sep; 44(9):1902-11. PubMed ID: 23664541
[TBL] [Abstract][Full Text] [Related]
23. [ETV6-rearranged low-grade sinonasal non-intestinal-type adenocarcinoma: a clinicopathological analysis].
Zhai CW; Yuan CC; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):55-59. PubMed ID: 33396988
[No Abstract] [Full Text] [Related]
24. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
[TBL] [Abstract][Full Text] [Related]
25. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.
Sinicrope FA; Shi Q; Smyrk TC; Thibodeau SN; Dienstmann R; Guinney J; Bot BM; Tejpar S; Delorenzi M; Goldberg RM; Mahoney M; Sargent DJ; Alberts SR
Gastroenterology; 2015 Jan; 148(1):88-99. PubMed ID: 25305506
[TBL] [Abstract][Full Text] [Related]
26. Sinonasal low-grade non-intestinal-type adenocarcinoma: A retrospective analysis and literature review.
Yue C; Piao Y; Bai Y; Liu H; Zhang L
Ann Diagn Pathol; 2021 Jun; 52():151709. PubMed ID: 33550111
[TBL] [Abstract][Full Text] [Related]
27. SMARCB1(INI1)-deficient sinonasal adenocarcinoma: Report of a case previously diagnosed as high-grade non-intestinal-type sinonasal adenocarcinoma.
Su YJ; Lee YH; Hsieh MS
Pathol Int; 2022 Jan; 72(1):53-58. PubMed ID: 34597447
[TBL] [Abstract][Full Text] [Related]
28. Sialadenoma papilliferum-like intraductal papillary tumour: an emerging entity with intercalated duct differentiation showing MAPK pathway activation in both ductal and myoepithelial cells.
Oh KY; Kim JH; Hong SD; Yoon HJ
Pathology; 2024 Feb; 56(1):52-58. PubMed ID: 37973455
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical and genetic analysis of respiratory epithelial adenomatoid hamartomas and seromucinous hamartomas: are they precursor lesions to sinonasal low-grade tubulopapillary adenocarcinomas?
Baněčková M; Michal M; Laco J; Leivo I; Ptáková N; Horáková M; Michal M; Skálová A
Hum Pathol; 2020 Mar; 97():94-102. PubMed ID: 31698004
[TBL] [Abstract][Full Text] [Related]
30. Sinonasal Adenocarcinoma: Update on Classification, Immunophenotype and Molecular Features.
Leivo I
Head Neck Pathol; 2016 Mar; 10(1):68-74. PubMed ID: 26830399
[TBL] [Abstract][Full Text] [Related]
31. A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes.
Suurmeijer AJH; Dickson BC; Swanson D; Zhang L; Sung YS; Cotzia P; Fletcher CDM; Antonescu CR
Genes Chromosomes Cancer; 2018 Dec; 57(12):611-621. PubMed ID: 30276917
[TBL] [Abstract][Full Text] [Related]
32. Biphasic squamoid alveolar papillary renal cell carcinoma: A unique papillary renal cell carcinoma with distinctive morphology, immunophenotype and molecular genetic features.
Li Y; Wu X; Yang J; Jiang Y; Li Y; Zhang W; Yu W
Pathol Res Pract; 2022 Nov; 239():154120. PubMed ID: 36201928
[TBL] [Abstract][Full Text] [Related]
33. MSI-High RAS-BRAF wild-type colorectal adenocarcinomas with MLH1 loss have a high frequency of targetable oncogenic gene fusions whose diagnoses are feasible using methods easy-to-implement in pathology laboratories.
Bocciarelli C; Caumont C; Samaison L; Cariou M; Aline-Fardin A; Doucet L; Roudié J; Terris B; Merlio JP; Marcorelles P; Cappellen D; Uguen A
Hum Pathol; 2021 Aug; 114():99-109. PubMed ID: 34019865
[TBL] [Abstract][Full Text] [Related]
34. SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas: An Analysis With Newly Found Molecular Alterations and Some Population-Based Molecular Differences.
Wroblewska JP; Mull J; Wu CL; Fujimoto M; Ogawa T; Marszalek A; Hoang MP
Am J Surg Pathol; 2019 Feb; 43(2):168-177. PubMed ID: 30273197
[TBL] [Abstract][Full Text] [Related]
35. Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.
Bishop JA; Weinreb I; Swanson D; Westra WH; Qureshi HS; Sciubba J; MacMillan C; Rooper LM; Dickson BC
Am J Surg Pathol; 2019 Aug; 43(8):1023-1032. PubMed ID: 31094920
[TBL] [Abstract][Full Text] [Related]
36. Salivary Sialadenoma Papilliferum Consists of Two Morphologically, Immunophenotypically, and Genetically Distinct Subtypes.
Hsieh MS; Bishop JA; Wang YP; Poh CF; Cheng YL; Lee YH; Jin YT; Chang JYF
Head Neck Pathol; 2020 Jun; 14(2):489-496. PubMed ID: 31473937
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing.
Wang J; Li R; Li J; Yi Y; Liu X; Chen J; Zhang H; Lu J; Li C; Wu H; Liang Z
J Transl Med; 2021 Oct; 19(1):433. PubMed ID: 34657620
[TBL] [Abstract][Full Text] [Related]
38. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance.
Yom SS; Rashid A; Rosenthal DI; Elliott DD; Hanna EY; Weber RS; El-Naggar AK
Mod Pathol; 2005 Mar; 18(3):315-9. PubMed ID: 15492756
[TBL] [Abstract][Full Text] [Related]
39. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
[TBL] [Abstract][Full Text] [Related]
40. Sinonasal tubulopapillary low-grade adenocarcinoma. Histopathological, immunohistochemical and ultrastructural features of poorly recognised entity.
Skalova A; Cardesa A; Leivo I; Pfaltz M; Ryska A; Simpson R; Michal M
Virchows Arch; 2003 Aug; 443(2):152-8. PubMed ID: 12827515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
